Genocea Biosciences Licenses Portfolio of Vaccine Targets from Harvard Medical School

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced the license to 14 antigens to Chlamydia trachomatis discovered in the lab of Dr. Darren Higgins, Associate Professor of Microbiology and Molecular Genetics at Harvard Medical School and scientific founder of Genocea.

Back to news